查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
營養補充劑 CDMO 市場 - 增長、未來前景、競爭分析，2023-2031 年
市場調查報告書
商品編碼
1313727

營養補充劑 CDMO 市場 - 增長、未來前景、競爭分析，2023-2031 年

Nutraceuticals CDMO Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

由於對定制營養補充劑以及製造和開發流程外包的需求不斷增加，營養補充劑 CDMO（合同開發和製造組織）市場正在經歷顯著增長。 這一市場是專門的 CDMO 為營養保健品公司提供配方開發、製造、包裝和其他相關服務的市場。 由於營養保健品行業的不斷擴大以及對具有成本效益和高效的製造解決方案的需求，預計未來幾年營養保健品 CDMO 市場收入將顯著增長。 預計 2023 年至 2031 年期間，全球營養保健品 CDMO 市場將以 7.9% 的複合年增長率增長。 這種增長是由於消費者健康意識增強、人口老齡化以及慢性病患病率上升等因素造成的。 營養保健品公司越來越依賴 CDMO 來利用其專業知識、能力和基礎設施來加速產品開發和簡化製造流程。

定制營養補充劑的需求不斷增加

營養補充劑市場對滿足特定消費者需求的定制產品的需求正在激增。 這種動態是由多種因素推動的，包括消費者偏好的變化、對預防性保健的興趣增加以及對營養補充劑潛在健康益處的認識提高。 如今的消費者正在尋找個性化和有針對性的解決方案，以解決他們獨特的健康問題和目標。 這種定制需求為營養保健品公司提供定制產品創造了巨大的機會。 CDMO 在滿足這種定制需求方面發揮著至關重要的作用。 憑藉配方開發方面的專業知識和對最新市場趨勢的了解，CDMO 可以幫助營養保健品公司創造符合消費者偏好的創新產品。 CDMO 為優化產品功效和吸引力的成分選擇、劑型和輸送系統提供了寶貴的見解。 通過與 CDMO 合作，營養保健品公司可以開發與目標消費者產生共鳴的獨特且差異化的產品。

製造和開發流程外包

營養保健品 CDMO 市場的一個顯著驅動因素是營養保健品公司外包製造和開發流程的趨勢不斷增長。 這一驅動因素主要是出於簡化運營、降低成本以及專注於營銷、銷售和產品創新等核心能力的願望。 通過與 CDMO 合作，營養保健品公司可以利用 CDMO 的專業知識和基礎設施來優化其製造流程。 CDMO擁有先進的設備、設施和技術專長，確保高效生產和高質量標準。 CDMO 提供端到端解決方案，包括配方開發、原材料採購、製造、包裝和監管合規。 通過將製造和開發流程外包給 CDMO，營養保健品公司獲得了靈活性和可擴展性。 適應不斷變化的市場需求並有效管理生產波動，無需大量資本投資。 此外，CDMO 還可以通過規模經濟、資源共享和供應鏈管理專業知識來提高成本效率。

監管合規性和質量保證

監管合規和質量保證是營養藥品 CDMO 市場的關鍵驅動因素。 營養保健品行業須遵守嚴格的監管要求，以確保產品安全、功效並符合當地或國際標準。 遵守這些法規對於保護消費者的健康和維護膳食補充劑公司的聲譽至關重要。 CDMO 在幫助營養保健品公司滿足這些監管標準方面發揮著關鍵作用。 CDMO 對監管環境有深入的了解，可以指導公司滿足複雜的要求。 CDMO 促進遵守良好生產規範 (GMP) 並進行質量保證測試，以確保產品符合所需的規格和標準。 通過與 CDMO 合作，營養保健品公司可以降低與監管不合規相關的風險。 CDMO 的質量控制、文件記錄和監管提交專業知識確保產品的開發、製造和分銷符合監管指南。 這是由於消費者安全擔憂的增加、遵守不斷變化的監管框架的需要以及不合規的潛在法律和財務後果所驅動的。

監管合規挑戰

市場條件的潛在限制之一是複雜且不斷變化的監管環境。 營養保健品行業須遵守監管機構的各種法規和指南，以確保產品的安全性、有效性和合規性。 滿足這些監管要求對於膳食補充劑公司和 CDMO 來說都是一個挑戰。 膳食補充劑受到嚴格的監管，以確保消費者安全和產品質量。 CDMO 必須遵守良好生產規範 (GMP)、標籤要求和產品標籤等法規。 遵守不同區域或國際法規的需要可能在一致性和效率方面構成挑戰。 膳食補充劑的監管環境在不斷發展。 可能會引入新的法規、指南和標籤要求，並且可能會修改現有法規。 CDMO 適應這些變化並確保合規性需要時間和資源，並且可能會影響運營和時間表。 膳食補充劑行業在不同地區和國家運營，每個地區和國家都有自己的監管框架。 服務於全球的 CDMO 必須滿足許多監管要求，這些要求因市場而異。 遵守這些差異會增加複雜性並增加 CDMO 的負擔。 雖然監管合規性挑戰可能是營養藥品 CDMO 市場的一個限制因素，但這些挑戰為 CDMO 提供了一個機會，通過提供監管專業知識和確保客戶合規性來脫穎而出。

藥丸和膠囊：膳食補充劑輸送的支柱

膳食補充劑 CDMO 市場按片劑/膠囊、粉末、軟膠囊和其他劑型細分。 每種劑型都有其自身的特點和優點，可滿足不同消費者的喜好和要求。 片劑和膠囊是膳食補充劑行業最常見的劑型。 這些劑型方便、劑量精確且易於攝入。 這些劑型因其熟悉且易於融入日常生活而深受消費者歡迎。 膳食補充劑 CDMO 市場以片劑和膠囊銷售為主。 片劑和膠囊被廣泛使用，並且由於消費者對傳統固體劑型的偏好，預計其需求將持續增長。 其他類別包括營養藥品 CDMO 市場中的各種創新新劑型，例如軟糖、液體、噴霧劑和舌下製劑。 這些劑型提供獨特的遞送機制和消費者體驗。 其他細分市場的特點是利基產品，預計在消費者對新穎、方便劑型的需求的推動下將出現顯著增長。

製造和包裝：引領膳食補充劑 CDMO 市場

製造和包裝服務包括大規模膳食補充劑的製造和包裝。 這包括混合、封裝、壓片、標籤和包裝等過程。 這些服務對於確保高效且合規的製造運營至關重要。 由於對可靠、高質量製造能力的需求，製造和包裝服務預計將佔收入的很大一部分。 膳食補充劑 CDMO 市場的監管合規服務預計將出現相對較高的複合年增長率，因為它們在確保市場准入和消費者信心方面發揮著關鍵作用。 這些服務在確保膳食補充劑產品滿足監管機構制定的嚴格要求和標準方面發揮著重要作用。 這些服務包括協調複雜的監管框架、獲得所需的認證、進行審核、確保產品安全和合規性等等。 對膳食補充劑行業日益嚴格的監管審查，加上消費者安全和產品質量日益增長的擔憂，正在推動對強大的監管合規服務的需求。 隨著監管環境不斷發展並變得更加嚴格，膳食補充劑公司開始求助於專門從事監管合規的 CDMO，以幫助他們有效應對這一複雜的環境。

北美：收入和市場佔有率領先

北美在膳食補充劑 CDMO 市場中佔據了很大的收入份額，這得益於其強大的市場影響力、先進的製造能力和明確的監管框架。 這一強勁的市場地位反映了消費者對營養補充劑和功能性食品的需求不斷增長，原因包括對預防性保健的興趣日益濃厚、健康意識不斷增強以及健康意識生活方式的採用等。 亞太地區是市場上一個充滿活力且高增長的地區，各種因素推動了膳食補充劑的需求。 該地區人口眾多、可支配收入不斷增加、生活方式不斷變化以及中產階級不斷壯大，為營養補充劑創造了肥沃的市場環境。 中國、日本和印度等國家在推動亞太地區市場增長方面發揮著關鍵作用。 中國人口眾多，為營養藥品 CDMO 滿足不斷增長的消費者需求提供了巨大的機會。 該國不斷壯大的中產階級以及對健康和保健日益增長的興趣正在推動對營養補充劑和功能性食品的需求激增。 同樣，在老齡化社會和強調預防醫學的文化的推動下，日本也建立了營養補充劑市場。 印度中產階級不斷擴大，健康意識不斷增強，也對該地區的市場增長做出了重大貢獻。

競爭格局

目錄

第一章前言

  • 報告內容
    • 報告的目的
    • 目標受眾
    • 主要產品
  • 市場細分
  • 調查方法
    • 第一階段 - 二次調查
    • 第二階段 - 初步調查
    • 第三階段 - 專家評審
    • 先決條件
    • 採用的方法

第 2 章執行摘要

第三章膳食補充劑 CDMO 市場：競爭分析

  • 主要供應商的市場定位
  • 供應商採取的策略
  • 主要產業戰略
  • 層級分析：2022 年與 2031 年

第四章營養補充劑 CDMO 市場：宏觀分析和市場動態

  • 簡介
  • 2021-2031年全球營養補充劑CDMO市場價值
  • 市場動態
    • 市場驅動因素
    • 市場製約因素
    • 主要問題
    • 主要機會
  • 促進因素和抑制因素的影響分析
  • 蹺蹺板分析

第 5 章營養補充劑 CDMO 市場：按劑型 2021-2031

  • 市場概覽
  • 增長/利潤分析：2022 年與 2031 年
  • 市場細分
    • 藥丸和膠囊
    • 粉末
    • 軟凝膠
    • 其他

第 6 章營養補充劑 CDMO 市場：按服務分類 2021-2031

  • 市場概覽
  • 增長/利潤分析：2022 年與 2031 年
  • 市場細分
    • 產品配方和開發
    • 製造和包裝
    • 研究與開發 (R&D)
    • 監管合規性
    • 其他

第 7 章營養補充劑 CDMO 市場：按公司規模劃分 2021-2031

  • 市場概覽
  • 增長/利潤分析：2022 年與 2031 年
  • 市場細分
    • 中小企業
    • 中型企業
    • 大型公司

第8章2021-2031年北美營養補充劑CDMO市場

  • 市場概覽
  • 營養藥品 CDMO 市場：按劑型分類 2021-2031
  • 營養藥品 CDMO 市場：按服務分類 2021-2031 年
  • 營養藥品 CDMO 市場：按公司規模劃分，2021-2031 年
  • 營養藥品 CDMO 市場：按地區劃分 2021-2031 年
    • 北美
      • 美國
      • 加拿大
      • 其他北美地區

第 9 章英國和歐盟膳食補充劑 CDMO 市場 2021-2031

  • 市場概覽
  • 營養藥品 CDMO 市場：按劑型分類 2021-2031
  • 膳食補充劑 CDMO 市場：按服務分類 2021-2031 年
  • 膳食補充劑 CDMO 市場：按公司規模劃分，2021-2031 年
  • 膳食補充劑 CDMO 市場：按地區劃分 2021-2031 年
    • 英國和歐盟
      • 英國
      • 德國
      • 西班牙
      • 意大利
      • 法國
      • 其他歐洲地區

第 10 章 2021-2031 年亞太營養藥品 CDMO 市場

  • 市場概覽
  • 膳食補充劑 CDMO 市場：按配方劃分 2021-2031 年
  • 膳食補充劑 CDMO 市場：按服務分類 2021-2031 年
  • 膳食補充劑 CDMO 市場：按公司規模劃分，2021-2031 年
  • 膳食補充劑 CDMO 市場：按地區劃分 2021-2031 年
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區

第 11 章 2021-2031 年拉丁美洲營養藥品 CDMO 市場

  • 市場概覽
  • 膳食補充劑 CDMO 市場：按配方劃分 2021-2031 年
  • 膳食補充劑 CDMO 市場：按服務分類 2021-2031 年
  • 膳食補充劑 CDMO 市場：按公司規模劃分，2021-2031 年
  • 膳食補充劑 CDMO 市場：按地區劃分 2021-2031 年
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地區

第12章中東和非洲膳食補充劑 CDMO 市場 2021-2031

  • 市場概覽
  • 膳食補充劑 CDMO 市場：按配方劃分 2021-2031 年
  • 膳食補充劑 CDMO 市場：按服務分類 2021-2031 年
  • 營養藥品 CDMO 市場：按公司規模劃分，2021-2031 年
  • 營養藥品 CDMO 市場：按地區劃分 2021-2031 年
    • 中東/非洲
      • 海灣合作委員會
      • 非洲
      • 其他中東/非洲地區

第13章公司簡介

  • Catalent Lonza Group
  • Royal DSM
  • BASF
  • Kerry Group
  • Archer Daniels Midland
  • Glanbia
  • Capsugel
  • Aenova Group
  • NutraScience Labs
  • Nutragenesis
  • Pharmavite
  • SirioPharma
  • Balchem Corporation
  • SirioPharma International
  • 其他主要企業
Product Code: 139651-07-23

The nutraceuticals CDMO (Contract Development and Manufacturing Organization) market is experiencing substantial growth due to increasing demand for customized nutraceutical products and the outsourcing of manufacturing and development processes. This market involves the provision of contract services by specialized CDMOs to nutraceutical companies for formulation development, manufacturing, packaging, and other related services. The market revenue for nutraceuticals CDMO is projected to grow significantly in the coming years, driven by the expanding nutraceutical industry and the need for cost-effective and efficient manufacturing solutions.The global nutraceuticals CDMO market is projected to grow at a CAGR of 7.9% during the forecast period of 2023 to 2031. This growth is attributed to factors such as the rising consumer awareness about health and wellness, the growing aging population, and the increasing prevalence of chronic diseases. Nutraceutical companies are increasingly relying on CDMOs to leverage their expertise, capabilities, and infrastructure to accelerate product development and streamline manufacturing processes.

Increasing Demand for Customized Nutraceutical Products

The nutraceuticals market is witnessing a surge in the demand for customized products that cater to specific consumer needs. This driver is propelled by several factors, including shifting consumer preferences, a growing focus on preventive healthcare, and the rising awareness of the potential health benefits offered by nutraceuticals. Consumers today seek personalized and targeted solutions that address their unique health concerns and goals. This demand for customization creates a significant opportunity for nutraceutical companies to offer tailored products. CDMOs play a pivotal role in meeting this demand for customization. With their expertise in formulation development and understanding of the latest market trends, CDMOs can help nutraceutical companies create innovative products that align with consumer preferences. They provide valuable insights into ingredient selection, dosage forms, and delivery systems that optimize the effectiveness and appeal of the products. By collaborating with CDMOs, nutraceutical companies can develop unique and differentiated offerings that resonate with their target consumers.

Outsourcing of Manufacturing and Development Processes

A prominent driver in the nutraceuticals CDMO market is the increasing trend of outsourcing manufacturing and development processes by nutraceutical companies. This driver is primarily motivated by the desire to streamline operations, reduce costs, and focus on core competencies such as marketing, sales, and product innovation. By partnering with CDMOs, nutraceutical companies can leverage their specialized capabilities and infrastructure to optimize manufacturing processes. CDMOs possess advanced equipment, facilities, and technical expertise to ensure efficient production and high-quality standards. They offer end-to-end solutions, including formulation development, ingredient sourcing, manufacturing, packaging, and regulatory compliance. Outsourcing manufacturing and development processes to CDMOs provides nutraceutical companies with flexibility and scalability. They can adapt to changing market demands and efficiently manage fluctuations in production volumes without incurring significant capital investments. Moreover, CDMOs can offer cost efficiencies through economies of scale, shared resources, and expertise in supply chain management.

Regulatory Compliance and Quality Assurance

Regulatory compliance and quality assurance are crucial drivers in the nutraceuticals CDMO market. The nutraceuticals industry is subject to stringent regulatory requirements to ensure product safety, efficacy, and compliance with regional or international standards. Compliance with these regulations is vital to protect consumer health and maintain the reputation of nutraceutical companies. CDMOs play a critical role in supporting nutraceutical companies in meeting these regulatory standards. They possess in-depth knowledge of the regulatory landscape and can guide companies through complex requirements. CDMOs facilitate adherence to Good Manufacturing Practices (GMP) and conduct quality assurance testing to ensure that products meet the necessary specifications and standards. By partnering with CDMOs, nutraceutical companies can mitigate the risks associated with regulatory non-compliance. CDMOs' expertise in quality control, documentation, and regulatory submissions ensures that products are developed, manufactured, and distributed in accordance with regulatory guidelines. This driver is driven by the increasing focus on consumer safety, the need to adhere to evolving regulatory frameworks, and the potential legal and financial consequences of non-compliance.

Regulatory Compliance Challenges

One of the potential restraints in the nutraceuticals CDMO market is the complex and ever-changing regulatory landscape. The nutraceutical industry is subject to various regulations and guidelines imposed by regulatory authorities to ensure product safety, efficacy, and compliance. Meeting these regulatory requirements can be challenging for both nutraceutical companies and CDMOs. Nutraceutical products are subject to rigorous regulatory scrutiny to ensure consumer safety and product quality. Compliance with regulations such as Good Manufacturing Practices (GMP), labeling requirements, and product claims can be demanding for CDMOs. The need to adhere to diverse regional or international regulations can pose challenges in terms of consistency and efficiency. The regulatory landscape for nutraceuticals is continuously evolving. New regulations, guidelines, and labeling requirements are introduced, and existing regulations may undergo revisions. Keeping up with these changes and ensuring compliance can be time-consuming and resource-intensive for CDMOs, potentially impacting their operations and timelines. The nutraceutical industry operates in different regions and countries, each with its own regulatory framework. CDMOs that offer services globally need to navigate through a multitude of regulatory requirements, which can differ significantly from one market to another. Adhering to these variations adds complexity and increases the burden on CDMOs. While regulatory compliance challenges can pose a restraint in the nutraceuticals CDMO market, it is important to note that these challenges can also present opportunities for CDMOs to differentiate themselves by providing regulatory expertise and ensuring compliance for their clients.

Tablets & Capsules: Pillars of Nutraceutical Delivery

The nutraceuticals CDMO market is segmented by dosage forms, including tablets & capsules, powder, softgel, and others. Each dosage form has its own characteristics and benefits, catering to different consumer preferences and requirements. Tablets and capsules are one of the most common dosage forms in the nutraceutical industry. They offer convenience, precise dosing, and ease of consumption. These dosage forms are popular among consumers due to their familiarity and ease of incorporating into daily routines. Tablets and capsules accounted for a significant revenue percentage in the nutraceuticals CDMO market. The demand for tablets and capsules is expected to continue due to their widespread use and consumer preference for traditional solid dosage forms. The others category includes various innovative and emerging dosage forms in the nutraceuticals CDMO market, such as gummies, liquids, sprays, and sublingual formulations. These dosage forms offer unique delivery mechanisms and consumer experiences. The others segment is characterized by niche products and is expected to witness notable growth, driven by consumer demand for novel and convenient dosage formats.

Manufacturing and Packaging: Leading the Nutraceuticals CDMO Market

Manufacturing and packaging services encompass the production and packaging of nutraceutical products at scale. This includes processes such as blending, encapsulation, tableting, labeling, and packaging. These services are crucial for ensuring efficient and compliant manufacturing operations. Manufacturing and packaging services are anticipated to hold a significant revenue percentage due to the demand for reliable and high-quality production capabilities. Regulatory compliance services in the nutraceuticals CDMO market are expected to witness a relatively high CAGR due to their critical role in ensuring market access and consumer trust. These services play a vital role in helping nutraceutical products meet the stringent requirements and standards set by regulatory authorities. They involve navigating complex regulatory frameworks, obtaining necessary certifications, conducting audits, and ensuring product safety and compliance. The increasing regulatory scrutiny on the nutraceutical industry, coupled with the rising focus on consumer safety and product quality, drives the demand for robust regulatory compliance services. As the regulatory landscape continues to evolve and become more stringent, nutraceutical companies rely on CDMOs specializing in regulatory compliance to navigate these complexities effectively.

North America: Leader in Revenue and Market Presence

North America holds a significant revenue share in the nutraceuticals CDMO market, driven by its robust market presence, advanced manufacturing capabilities, and well-defined regulatory framework. This strong market position can be attributed to the increasing consumer demand for dietary supplements and functional foods, driven by factors such as the growing focus on preventive healthcare, rising health consciousness, and the adoption of wellness-oriented lifestyles. Asia Pacific emerges as a dynamic and high-growth region in the nutraceuticals CDMO market, fueled by various factors that drive the demand for nutraceutical products. The region's large population base, rising disposable income, shifting lifestyles, and the growing middle class create a fertile market landscape for nutraceuticals. Countries like China, Japan, and India play a pivotal role in driving the market growth in the Asia Pacific region. With its massive population, China presents substantial opportunities for nutraceuticals CDMOs to cater to the increasing consumer demand. The rising middle class in the country, coupled with a growing focus on health and wellness, has led to a surge in demand for dietary supplements and functional foods. Similarly, Japan has a well-established nutraceutical market, driven by the aging population and the cultural emphasis on preventive healthcare. India, with its expanding middle class and rising health awareness, is also a key contributor to the region's market growth.

Competitive Landscape

The Nutraceuticals CDMO market features a competitive landscape with key players such as Catalent, Lonza Group, Royal DSM, BASF, Kerry Group, Archer Daniels Midland, Glanbia, Capsugel, Aenova Group, NutraScience Labs, Nutragenesis, Pharmavite, SirioPharma, Balchem Corporation, and SirioPharma International. These companies provide a wide range of services including formulation development, manufacturing, packaging, and quality control for nutraceutical products. The market's competitive trends are driven by factors such as innovation, technological advancements, geographic expansion, strategic partnerships, and acquisitions aimed at enhancing capabilities and expanding service offerings.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofNutraceuticals CDMO market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Nutraceuticals CDMO market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Dosage Forms

  • Tablets & Capsules
  • Powder
  • Softgel
  • Others

Services

  • Product Formulation and Development
  • Manufacturing and Packaging
  • Research and Development (R&D)
  • Regulatory Compliance
  • Others

Company Size

  • Small Companies
  • Mid-Sized Companies
  • Large Companies

Region Segment (2021-2031; US$ Million)

  • North America
  • U.S.
  • Canada
  • Rest of North America
  • UK and European Union
  • UK
  • Germany
  • Spain
  • Italy
  • France
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East and Africa
  • GCC
  • Africa
  • Rest of Middle East and Africa

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Nutraceuticals CDMO market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Nutraceuticals CDMO market?
  • Which is the largest regional market for Nutraceuticals CDMO market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Nutraceuticals CDMO market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Nutraceuticals CDMO market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Nutraceuticals CDMO Market
  • 2.2. Global Nutraceuticals CDMO Market, By Dosage Forms, 2022 (US$ Million)
  • 2.3. Global Nutraceuticals CDMO Market, By Services, 2022 (US$ Million)
  • 2.4. Global Nutraceuticals CDMO Market, By Company Size, 2022 (US$ Million)
  • 2.5. Global Nutraceuticals CDMO Market, By Geography, 2022 (US$ Million)
  • 2.6. Attractive Investment Proposition by Geography, 2022

3. Nutraceuticals CDMO Market: Competitive Analysis

  • 3.1. Market Positioning of Key Nutraceuticals CDMO Market Vendors
  • 3.2. Strategies Adopted by Nutraceuticals CDMO Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Nutraceuticals CDMO Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Nutraceuticals CDMO Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis

5. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Tablets & Capsules
    • 5.3.2. Powder
    • 5.3.3. Softgel
    • 5.3.4. Others

6. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Product Formulation and Development
    • 6.3.2. Manufacturing and Packaging
    • 6.3.3. Research and Development (R&D)
    • 6.3.4. Regulatory Compliance
    • 6.3.5. Others

7. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Small Companies
    • 7.3.2. Mid-Sized Companies
    • 7.3.3. Large Companies

8. North America Nutraceuticals CDMO Market, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
  • 8.3. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
  • 8.4. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  • 8.5.Nutraceuticals CDMO Market: By Region, 2021-2031, USD (Million)
    • 8.5.1.North America
      • 8.5.1.1. U.S.
        • 8.5.1.1.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 8.5.1.1.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 8.5.1.1.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 8.5.1.2. Canada
        • 8.5.1.2.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 8.5.1.2.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 8.5.1.2.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 8.5.1.3. Rest of North America
        • 8.5.1.3.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 8.5.1.3.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 8.5.1.3.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)

9. UK and European Union Nutraceuticals CDMO Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
  • 9.3. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
  • 9.4. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  • 9.5.Nutraceuticals CDMO Market: By Region, 2021-2031, USD (Million)
    • 9.5.1.UK and European Union
      • 9.5.1.1. UK
        • 9.5.1.1.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 9.5.1.1.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 9.5.1.1.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 9.5.1.2. Germany
        • 9.5.1.2.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 9.5.1.2.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 9.5.1.2.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 9.5.1.3. Spain
        • 9.5.1.3.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 9.5.1.3.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 9.5.1.3.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 9.5.1.4. Italy
        • 9.5.1.4.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 9.5.1.4.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 9.5.1.4.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 9.5.1.5. France
        • 9.5.1.5.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 9.5.1.5.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 9.5.1.5.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 9.5.1.6. Rest of Europe
        • 9.5.1.6.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 9.5.1.6.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 9.5.1.6.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)

10. Asia Pacific Nutraceuticals CDMO Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
  • 10.3. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
  • 10.4. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  • 10.5.Nutraceuticals CDMO Market: By Region, 2021-2031, USD (Million)
    • 10.5.1.Asia Pacific
      • 10.5.1.1. China
        • 10.5.1.1.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 10.5.1.1.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 10.5.1.1.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 10.5.1.2. Japan
        • 10.5.1.2.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 10.5.1.2.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 10.5.1.2.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 10.5.1.3. India
        • 10.5.1.3.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 10.5.1.3.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 10.5.1.3.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 10.5.1.4. Australia
        • 10.5.1.4.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 10.5.1.4.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 10.5.1.4.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 10.5.1.5. South Korea
        • 10.5.1.5.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 10.5.1.5.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 10.5.1.5.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 10.5.1.6. Rest of Asia Pacific
        • 10.5.1.6.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 10.5.1.6.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 10.5.1.6.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)

11. Latin America Nutraceuticals CDMO Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
  • 11.3. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
  • 11.4. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  • 11.5.Nutraceuticals CDMO Market: By Region, 2021-2031, USD (Million)
    • 11.5.1.Latin America
      • 11.5.1.1. Brazil
        • 11.5.1.1.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 11.5.1.1.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 11.5.1.1.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 11.5.1.2. Mexico
        • 11.5.1.2.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 11.5.1.2.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 11.5.1.2.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 11.5.1.3. Rest of Latin America
        • 11.5.1.3.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 11.5.1.3.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 11.5.1.3.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)

12. Middle East and Africa Nutraceuticals CDMO Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
  • 12.3. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
  • 12.4. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
  • 12.5.Nutraceuticals CDMO Market: By Region, 2021-2031, USD (Million)
    • 12.5.1.Middle East and Africa
      • 12.5.1.1. GCC
        • 12.5.1.1.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 12.5.1.1.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 12.5.1.1.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 12.5.1.2. Africa
        • 12.5.1.2.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 12.5.1.2.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 12.5.1.2.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)
      • 12.5.1.3. Rest of Middle East and Africa
        • 12.5.1.3.1. Nutraceuticals CDMO Market: By Dosage Forms, 2021-2031, USD (Million)
        • 12.5.1.3.2. Nutraceuticals CDMO Market: By Services, 2021-2031, USD (Million)
        • 12.5.1.3.3. Nutraceuticals CDMO Market: By Company Size, 2021-2031, USD (Million)

13. Company Profile

  • 13.1. Catalent, Lonza Group
    • 13.1.1. Company Overview
    • 13.1.2. Financial Performance
    • 13.1.3. Product Portfolio
    • 13.1.4. Strategic Initiatives
  • 13.2. Royal DSM
    • 13.2.1. Company Overview
    • 13.2.2. Financial Performance
    • 13.2.3. Product Portfolio
    • 13.2.4. Strategic Initiatives
  • 13.3. BASF
    • 13.3.1. Company Overview
    • 13.3.2. Financial Performance
    • 13.3.3. Product Portfolio
    • 13.3.4. Strategic Initiatives
  • 13.4. Kerry Group
    • 13.4.1. Company Overview
    • 13.4.2. Financial Performance
    • 13.4.3. Product Portfolio
    • 13.4.4. Strategic Initiatives
  • 13.5. Archer Daniels Midland
    • 13.5.1. Company Overview
    • 13.5.2. Financial Performance
    • 13.5.3. Product Portfolio
    • 13.5.4. Strategic Initiatives
  • 13.6. Glanbia
    • 13.6.1. Company Overview
    • 13.6.2. Financial Performance
    • 13.6.3. Product Portfolio
    • 13.6.4. Strategic Initiatives
  • 13.7. Capsugel
    • 13.7.1. Company Overview
    • 13.7.2. Financial Performance
    • 13.7.3. Product Portfolio
    • 13.7.4. Strategic Initiatives
  • 13.8. Aenova Group
    • 13.8.1. Company Overview
    • 13.8.2. Financial Performance
    • 13.8.3. Product Portfolio
    • 13.8.4. Strategic Initiatives
  • 13.9. NutraScience Labs
    • 13.9.1. Company Overview
    • 13.9.2. Financial Performance
    • 13.9.3. Product Portfolio
    • 13.9.4. Strategic Initiatives
  • 13.10. Nutragenesis
    • 13.10.1. Company Overview
    • 13.10.2. Financial Performance
    • 13.10.3. Product Portfolio
    • 13.10.4. Strategic Initiatives
  • 13.11. Pharmavite
    • 13.11.1. Company Overview
    • 13.11.2. Financial Performance
    • 13.11.3. Product Portfolio
    • 13.11.4. Strategic Initiatives
  • 13.12. SirioPharma
    • 13.12.1. Company Overview
    • 13.12.2. Financial Performance
    • 13.12.3. Product Portfolio
    • 13.12.4. Strategic Initiatives
  • 13.13. Balchem Corporation
    • 13.13.1. Company Overview
    • 13.13.2. Financial Performance
    • 13.13.3. Product Portfolio
    • 13.13.4. Strategic Initiatives
  • 13.14. SirioPharma International
    • 13.14.1. Company Overview
    • 13.14.2. Financial Performance
    • 13.14.3. Product Portfolio
    • 13.14.4. Strategic Initiatives
  • 13.15. Other Notable Players
    • 13.15.1. Company Overview
    • 13.15.2. Financial Performance
    • 13.15.3. Product Portfolio
    • 13.15.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 2 Global Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 3 Global Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 4 North America Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 5 North America Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 6 North America Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 7 U.S. Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 8 U.S. Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 9 U.S. Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 10 Canada Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 11 Canada Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 12 Canada Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 13 Rest of North America Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 14 Rest of North America Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 15 Rest of North America Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 16 UK and European Union Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 17 UK and European Union Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 18 UK and European Union Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 19 UK Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 20 UK Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 21 UK Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 22 Germany Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 23 Germany Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 24 Germany Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 25 Spain Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 26 Spain Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 27 Spain Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 28 Italy Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 29 Italy Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 30 Italy Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 31 France Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 32 France Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 33 France Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 34 Rest of Europe Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 35 Rest of Europe Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 36 Rest of Europe Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 37 Asia Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 38 Asia Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 39 Asia Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 40 China Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 41 China Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 42 China Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 43 Japan Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 44 Japan Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 45 Japan Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 46 India Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 47 India Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 48 India Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 49 Australia Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 50 Australia Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 51 Australia Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 52 South Korea Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 53 South Korea Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 54 South Korea Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 55 Latin America Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 56 Latin America Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 57 Latin America Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 58 Brazil Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 59 Brazil Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 60 Brazil Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 61 Mexico Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 62 Mexico Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 63 Mexico Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 64 Rest of Latin America Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 65 Rest of Latin America Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 66 Rest of Latin America Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 67 Middle East and Africa Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 68 Middle East and Africa Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 69 Middle East and Africa Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 70 GCC Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 71 GCC Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 72 GCC Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 73 Africa Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 74 Africa Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 75 Africa Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)
  • TABLE 76 Rest of Middle East and Africa Nutraceuticals CDMO Market By Dosage Forms, 2021-2031, USD (Million)
  • TABLE 77 Rest of Middle East and Africa Nutraceuticals CDMO Market By Services, 2021-2031, USD (Million)
  • TABLE 78 Rest of Middle East and Africa Nutraceuticals CDMO Market By Company Size, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Nutraceuticals CDMO Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Nutraceuticals CDMO Market: Quality Assurance
  • FIG. 5 Global Nutraceuticals CDMO Market, By Dosage Forms, 2022
  • FIG. 6 Global Nutraceuticals CDMO Market, By Services, 2022
  • FIG. 7 Global Nutraceuticals CDMO Market, By Company Size, 2022
  • FIG. 8 Global Nutraceuticals CDMO Market, By Geography, 2022
  • FIG. 9 Market Geographical Opportunity Matrix - Global Nutraceuticals CDMO Market, 2022

FIG. 10Market Positioning of Key Nutraceuticals CDMO Market Players, 2022

FIG. 11Global Nutraceuticals CDMO Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031

  • FIG. 12 Global Nutraceuticals CDMO Market, By Dosage Forms, 2022 Vs 2031, %
  • FIG. 13 Global Nutraceuticals CDMO Market, By Services, 2022 Vs 2031, %
  • FIG. 14 Global Nutraceuticals CDMO Market, By Company Size, 2022 Vs 2031, %
  • FIG. 15 U.S. Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 16 Canada Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 17 Rest of North America Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 18 UK Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 19 Germany Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 20 Spain Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 21 Italy Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 22 France Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 23 Rest of Europe Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 24 China Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 25 Japan Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 26 India Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 27 Australia Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 28 South Korea Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 29 Rest of Asia Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 30 Brazil Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 31 Mexico Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 32 Rest of Latin America Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 33 GCC Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 34 Africa Nutraceuticals CDMO Market (US$ Million), 2021 - 2031
  • FIG. 35 Rest of Middle East and Africa Nutraceuticals CDMO Market (US$ Million), 2021 - 2031